Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Human coronavirus OC43 3C-like protease (hCoV-OC43 3CLpro), also known as the main protease (Mpro) or non-structural protein 5 (nsp5), is an essential enzyme for the life cycle of the hCoV-OC43 virus [1, 2]. As a cysteine protease, it functions as a homodimer and is responsible for the proteolytic processing of the viral polyproteins pp1a and pp1ab into functional non-structural proteins [1, 8]. This cleavage is a prerequisite for the assembly of the viral replication-transcription complex, making the enzyme indispensable for viral replication [4, 10]. hCoV-OC43 is a major cause of the common cold and can lead to more severe respiratory tract infections in vulnerable populations [13, 14]. Due to its critical role and high conservation among coronaviruses, 3CLpro is a primary target for the development of broad-spectrum antiviral therapeutics [1, 8]. Drugs such as nirmatrelvir and various experimental peptidomimetics interact with the enzyme's active site, often forming covalent bonds with the catalytic cysteine residue to inhibit its activity [2, 8]. Successful inhibition of this protease effectively halts the production of new viral particles, providing a robust mechanism for treating coronavirus infections [4, 11].
Inhibition of viral polyprotein cleavage by binding to the active site of the 3C-like protease, thereby preventing the maturation of non-structural proteins and halting viral replication.
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human coronavirus OC43 3C-like protease (3CLpro).